H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report)’s stock price was down 49.5% during trading on Tuesday . The company traded as low as $2.02 and last traded at $2.02. Approximately 400 shares traded hands during mid-day trading, an increase of 288% from the average daily volume of 103 shares. The stock had previously closed at $4.00.
H-CYTE Price Performance
The business’s 50-day simple moving average is $2.02 and its 200 day simple moving average is $2.02.
About H-CYTE
H-CYTE, Inc, a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease.
Featured Articles
- Five stocks we like better than H-CYTE
- Comparing and Trading High PE Ratio Stocks
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Why Are These Companies Considered Blue Chips?
- Netflix Is On Track To Hit $1,000 By Christmas
- Ride Out The Recession With These Dividend Kings
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for H-CYTE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H-CYTE and related companies with MarketBeat.com's FREE daily email newsletter.
